Lazertinib (mesylate), CAS [[2247995-37-3]]

Produktübersicht

• Artikelname: Lazertinib (mesylate), CAS [[2247995-37-3]]
• Artikelnummer: MCE-HY-109061B
• Hersteller Artikelnummer: HY-109061B
• Alternativnummer: MCE-HY-109061B-25MG,MCE-HY-109061B-5MG,MCE-HY-109061B-10MMX1ML,MCE-HY-109061B-50MG,MCE-HY-109061B-100MG,MCE-HY-109061B-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: YH25448 (mesylate), GNS-1480 (mesylate)

Produktbeschreibung

Lazertinib (mesylate) (YH25448 (mesylate), GNS-1480 (mesylate)) is an orally active EGFR inhibitor that can penetrate the blood-brain barrier. Lazertinib (mesylate) inhibits p-EGFR, p-AKT and p-ERK signaling pathways, leading to apoptosis. Lazertinib (mesylate) has anti-tumor activity in the mouse H1975-luc BM xenograft model. Lazertinib (mesylate) can be used in the study of non-small cell lung cancer[1].

Produkteigenschaften

• Molekulargewicht: 650.75
• Reinheit: 99.85
• CAS Nummer: [2247995-37-3]
• Formel: C31H38N8O6S
• Target-Kategorie: Akt,EGFR,ERK

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound